Combination Chemotherapy With or Without Bevacizumab Compared With Bevacizumab Alone in Treating Patients With Advanced or Metastatic Colorectal Cancer That Has Been Previously Treated

This study has been completed.
Information provided by National Cancer Institute (NCI)

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:

1		Conditions listed in this trial
			Colorectal Cancer
2		Additional conditions recognized in this trial
			Colorectal Neoplasms
3		More general conditions related to this trial
			Colonic Diseases
			Digestive System Diseases
			Digestive System Neoplasms
			Gastrointestinal Diseases
			Gastrointestinal Neoplasms
			Intestinal Diseases
			Intestinal Neoplasms
			Neoplasms
			Neoplasms by Site
			Rectal Diseases
4		Interventions listed in this trial
			bevacizumab
			fluorouracil
			leucovorin calcium
			oxaliplatin
5		Additional drug interventions recognized in this trial
			Leucovorin
6		More general drug interventions related to this trial
			Angiogenesis Inhibitors
			Angiogenesis Modulating Agents
			Antimetabolites
			Antimetabolites, Antineoplastic
			Antineoplastic Agents
			Growth Inhibitors
			Growth Substances
			Immunologic Factors
			Immunosuppressive Agents
			Micronutrients
			Molecular Mechanisms of Pharmacological Action
			Pharmacologic Actions
			Physiological Effects of Drugs
			Therapeutic Uses
			Vitamin B Complex
			Vitamins
7		Sponsors listed in this trial
			Eastern Cooperative Oncology Group
			National Cancer Institute (NCI)